Literature DB >> 17853481

Zonisamide in patients with essential tremor and Parkinson's disease.

Pedro Emilio Bermejo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17853481     DOI： 10.1002/mds.21717

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  10 in total

1.  A review of the use of zonisamide in Parkinson's disease.

Authors:  Pedro Emilio Bermejo; Buenaventura Anciones
Journal:  Ther Adv Neurol Disord       Date:  2009-09       Impact factor: 6.570

2.  Zonisamide in managing impulse control disorders in Parkinson's disease.

Authors:  Pedro Emilio Bermejo; Cristina Ruiz-Huete; Buenaventura Anciones
Journal:  J Neurol       Date:  2010-05-28       Impact factor: 4.849

Review 3.  T-type calcium channel as a new therapeutic target for tremor.

Authors:  Hideto Miwa; Tomoyoshi Kondo
Journal:  Cerebellum       Date:  2011-09       Impact factor: 3.847

Review 4.  Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association.

Authors:  Mario Zappia; Alberto Albanese; Elisa Bruno; Carlo Colosimo; Graziella Filippini; Paolo Martinelli; Alessandra Nicoletti; Graziella Quattrocchi; Giovanni Abbruzzese; Alfredo Berardelli; Roberta Allegra; Maria Stella Aniello; Antonio E Elia; Davide Martino; Daniela Murgia; Marina Picillo; Giovanna Squintani
Journal:  J Neurol       Date:  2012-08-11       Impact factor: 4.849

5.  Anatomical localization of Cav3.1 calcium channels and electrophysiological effects of T-type calcium channel blockade in the motor thalamus of MPTP-treated monkeys.

Authors:  Annaelle Devergnas; Erdong Chen; Yuxian Ma; Ikuma Hamada; Damien Pittard; Stefan Kammermeier; Ariana P Mullin; Victor Faundez; Craig W Lindsley; Carrie Jones; Yoland Smith; Thomas Wichmann
Journal:  J Neurophysiol       Date:  2015-11-04       Impact factor: 2.714

6.  Initial treatment of Parkinson's disease: an update.

Authors:  Scott Kaplan; Daniel Tarsy
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

7.  Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated Monkeys.

Authors:  Adriana Galvan; Annaelle Devergnas; Damien Pittard; Gunasingh Masilamoni; Jocelyn Vuong; J Scott Daniels; Ryan D Morrison; Craig W Lindsley; Thomas Wichmann
Journal:  ACS Chem Neurosci       Date:  2016-09-20       Impact factor: 4.418

Review 8.  Zonisamide for essential tremor.

Authors:  Elisa Bruno; Alessandra Nicoletti; Graziella Filippini; Graziella Quattrocchi; Carlo Colosimo; Mario Zappia
Journal:  Cochrane Database Syst Rev       Date:  2017-08-24

9.  Zonisamide effects on sleep problems and depressive symptoms in Parkinson's disease.

Authors:  Keisuke Suzuki; Hiroaki Fujita; Takeo Matsubara; Yasuo Haruyama; Taro Kadowaki; Kei Funakoshi; Yuji Watanabe; Koichi Hirata
Journal:  Brain Behav       Date:  2021-01-05       Impact factor: 2.708

Review 10.  Current and Future Neuropharmacological Options for the Treatment of Essential Tremor.

Authors:  Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez; Félix J Jiménez-Jiménez
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.